People with severe rheumatoid arthritis (RA) can be depressed about their health situation and anxious about what lies ahead. A new study looked at just how many people with RA were depressed.

Clinicians are generally familiar with the side effects of most prescribed medications. However, the safety of newer medications such as golimumab, an anti-TNF drug to treat autoimmune disorders, is still being examined.

A few years ago, the FDA warned that certain drugs may raise the risk of cancer in children with juvenile arthritis. While it still seems these children are more prone to cancer, the drugs might not be to blame.

The inflammation of rheumatoid arthritis can affect more than the joints; it also poses a threat to the heart. When it comes to protecting the heart health of rheumatoid arthritis patients, certain drugs are falling short.